Troutman Pepper client Pyramid Laboratories, Inc., a leading drug product contract development and manufacturing organization (CDMO), has secured a growth investment from Audax Private Equity, a leading alternative investment manager and capital partner. Read a company press release about the investment.
Founded in 1988, Pyramid provides formulation development, analytical and stability testing, as well as aseptic fill-finish manufacturing services focused on large molecule therapeutics. The company has built a strong reputation for quality, technical expertise, and dedication to customer service with a comprehensive offering spanning preclinical development to scaled commercial manufacturing and distribution services.
The Troutman Pepper team advising Pyramid was led by Todd Boylan and Chris Miller (health sciences) and included Samantha Peruto, Daisy Flores, and Jenny Ji (corporate); Morgan Klinzing (tax); and Judy O’Grady (regulatory).
Troutman Pepper is a go-to firm for life sciences transactions with a large, multidisciplinary team with a deep understanding of the space. The firm regularly advises pharmaceutical, biotech, medical device, diagnostics, and other life sciences clients on all types of corporate matters — governance and general corporate advice; M&A transactions; licensing transactions and other complex collaborations; IPOs, follow-on public offerings, PIPE transactions, and other capital markets transactions; seed and later-stage venture capital financings; and much more.
Original source can be found here.